Choroidal Changes During and After Discontinuing Long-Term 0.01% Atropine Treatment for Myopia Control
On average, compared to placebo, 0.01% atropine eye drop treatment did not cause a differential rate of change in ChT during treatment, but abrupt cessation of long-term 0.01% atropine eye drops may disrupt normal choroidal thickening in children.
Authors
- Antony Clark (ORCID: https://orcid.org/0000-0001-8393-9870)
- David Alonso‐Caneiro (ORCID: https://orcid.org/0000-0002-7754-6592)
- Gareth Lingham (ORCID: https://orcid.org/0000-0002-8957-0733)
- Samantha Sze‐Yee Lee (ORCID: https://orcid.org/0000-0001-6635-1098)
- David A. Mackey (ORCID: https://orcid.org/0000-0001-7914-4709)
- Scott A. Read (ORCID: https://orcid.org/0000-0002-1595-673X)
Institutions
- Lions Eye Institute (AU)
- University of Tasmania (AU)
- Queensland University of Technology (AU)
- University of the Sunshine Coast (AU)
- The University of Western Australia (AU)
- Princess Margaret Hospital for Children (AU)
- Centre for Eye Research Australia (AU)
- ORCID (US)
- Technological University Dublin (IE)
- Perth Children's Hospital
Publication Details
- Journal
- Investigative Ophthalmology & Visual Science
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1167/iovs.65.10.21
- Citations
- 15
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 5.80
Funders
- Ophthalmic Research Institute of Australia
- Faculty of Health and Medical Sciences, University of Western Australia
- National Health and Medical Research Council